Literature DB >> 25228297

Correspondence of plasma and salivary cortisol patterns in women with breast cancer.

Jamie M Zeitzer1, Bita Nouriani, Eric Neri, David Spiegel.   

Abstract

INTRODUCTION: The 'diurnal slope' of salivary cortisol has been used as a measure of stress and circadian function in a variety of reports with several detailing its association with cancer progression. The relationship of this slope, typically a negative value from high morning concentrations to low evening concentrations, to the underlying daily variation in total plasma cortisol throughout the 24-hour cycle, however, has never been reported.
METHODS: To examine the relationship between the diurnal salivary cortisol slope and the underlying pattern of plasma cortisol in individuals with cancer, we examined a cohort of women with advanced breast cancer (n = 97) who had saliva and plasma collected during a modified 24-hour, constant posture protocol.
RESULTS: We found that the steepness of the diurnal slope of salivary cortisol was correlated with the amplitude of plasma cortisol rhythm when the slope was calculated from samples taken at wake + 30 min and 9 PM (r = -0.29, p > 0.05). Other variants of salivary slope calculations were not significantly correlated with the amplitude of the plasma cortisol rhythm. Diurnal salivary cortisol slope steepness was not correlated with the time between habitual waking and the computed circadian peak of cortisol, but there was a correlation between diurnal slope steepness and the time between habitual waking and the time of the awakening spike of morning cortisol (r values <-0.23, p values <0.05).
CONCLUSION: It therefore appears that in women with advanced breast cancer, diurnal salivary cortisol slope primarily represents aspects of the cortisol awakening response in relation to evening levels more than the circadian rhythm of total plasma cortisol.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25228297      PMCID: PMC4304942          DOI: 10.1159/000367925

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  37 in total

1.  Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods.

Authors:  A Chakraborty; W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

2.  Genetic factors, perceived chronic stress, and the free cortisol response to awakening.

Authors:  S Wüst; I Federenko; D H Hellhammer; C Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  2000-10       Impact factor: 4.905

Review 3.  Getting through to circadian oscillators: why use constant routines?

Authors:  Jeanne F Duffy; Derk-Jan Dijk
Journal:  J Biol Rhythms       Date:  2002-02       Impact factor: 3.182

Review 4.  Circadian and sleep-dependent regulation of hormone release in humans.

Authors:  C A Czeisler; E B Klerman
Journal:  Recent Prog Horm Res       Date:  1999

5.  Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.

Authors:  A N Vgontzas; E O Bixler; H M Lin; P Prolo; G Mastorakos; A Vela-Bueno; A Kales; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

6.  Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression.

Authors:  J M Zeitzer; D J Dijk; R Kronauer; E Brown; C Czeisler
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

7.  Diurnal cortisol rhythm as a predictor of breast cancer survival.

Authors:  S E Sephton; R M Sapolsky; H C Kraemer; D Spiegel
Journal:  J Natl Cancer Inst       Date:  2000-06-21       Impact factor: 13.506

8.  Diurnal cortisol rhythm as a predictor of lung cancer survival.

Authors:  Sandra E Sephton; Elizabeth Lush; Eric A Dedert; Andrea R Floyd; Whitney N Rebholz; Firdaus S Dhabhar; David Spiegel; Paul Salmon
Journal:  Brain Behav Immun       Date:  2012-08-03       Impact factor: 7.217

9.  Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals.

Authors:  A A Stone; J E Schwartz; J Smyth; C Kirschbaum; S Cohen; D Hellhammer; S Grossman
Journal:  Psychoneuroendocrinology       Date:  2001-04       Impact factor: 4.905

10.  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.

Authors:  Andrew Schrepf; Lauren Clevenger; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J Goodheart; Laila Dahmoush; Frank Penedo; Joseph A Lucci; Parvin Ganjei-Azar; Luis Mendez; Kristian Markon; David M Lubaroff; Premal H Thaker; George M Slavich; Anil K Sood; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2012-08-05       Impact factor: 7.217

View more
  4 in total

1.  Rigor and Reproducibility: A Systematic Review of Salivary Cortisol Sampling and Reporting Parameters Used in Cancer Survivorship Research.

Authors:  Jennifer M Hulett; Kristen L Fessele; Margaret F Clayton; Linda H Eaton
Journal:  Biol Res Nurs       Date:  2019-03-11       Impact factor: 2.522

2.  Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors.

Authors:  Andrew D Frugé; Mallory G Cases; Carrie R Howell; Yuko Tsuruta; Kelley Smith-Johnston; Douglas R Moellering; Wendy Demark-Wahnefried
Journal:  Cancer Causes Control       Date:  2017-11-23       Impact factor: 2.506

3.  Aberrant nocturnal cortisol and disease progression in women with breast cancer.

Authors:  Jamie M Zeitzer; Bita Nouriani; Michelle B Rissling; George W Sledge; Katherine A Kaplan; Linn Aasly; Oxana Palesh; Booil Jo; Eric Neri; Firdaus S Dhabhar; David Spiegel
Journal:  Breast Cancer Res Treat       Date:  2016-06-17       Impact factor: 4.872

4.  The Discovery of New Drug-Target Interactions for Breast Cancer Treatment.

Authors:  Jiali Song; Zhenyi Xu; Lei Cao; Meng Wang; Yan Hou; Kang Li
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.